Home > Insider Trading > Filing (0001181431-13-006146)

Filing Details

Accession Number:: 0001181431-13-006146
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-01 16:53:33
Reporting Period:: 2013-01-30

Filing Date:: 2013-02-01
Accepted Time:: 2013-02-01 16:53:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1407038	Bg Medicine Inc.	BGMD	In Vitro & In Vivo Diagnostic Substances (2835)	043506204

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1097546	Newcogen Equity Investors Llc	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1097548	Newcogen Group Llc	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1131095	Agtc Advisors Fund Lp	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1222012	Noubar Afeyan	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	Yes	No	Yes	No
1255927	Jr M Edwin Kania	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1399779	Applied Genomic Technology Capital Fund Lp	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1400240	Flagship Ventures Management, Inc.	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1400241	Newcogen Group, Inc.	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No
1419730	Agtc Partners, L.p.	C/O Flagship Ventures One Memorial Drive, 7Th Floor Cambridge MA 02142	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-30	250,000	$2.00	2,434,800	No	4	P	Indirect	By NewcoGen Group LLC
Common Stock	Acquisiton	2013-01-30	125,000	$2.00	651,560	No	4	P	Indirect	By NewcoGen Equity Investors LLC
Common Stock	Acquisiton	2013-01-30	75,000	$2.00	215,013	No	4	P	Indirect	By AGTC Advisors Fund, L.P.
Common Stock	Acquisiton	2013-01-30	500,000	$2.00	2,851,447	No	4	P	Indirect	By Applied Genomic Technology Capital Fund, L.P.
Common Stock	Acquisiton	2013-01-30	1,050,000	$2.00	1,764,286	No	4	P	Indirect	By Flagship Ventures Fund 2007, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By NewcoGen Group LLC
No	4	P	Indirect	By NewcoGen Equity Investors LLC
No	4	P	Indirect	By AGTC Advisors Fund, L.P.
No	4	P	Indirect	By Applied Genomic Technology Capital Fund, L.P.
No	4	P	Indirect	By Flagship Ventures Fund 2007, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	92,294	Indirect	By NewcoGen-Long Reign Holding LLC
Common Stock	92,126	Indirect	By ST NewcoGen LLC
Common Stock	4,232	Indirect	By OneLiberty Advisors Fund 2000 L.P.
Common Stock	80,424	Indirect	By OneLiberty Ventures 2000 L.P.

Footnotes

NewcoGen Group, Inc. ("NG") is the manager of each of NewcoGen Group LLC ("NGG"), NewcoGen Equity Investors LLC ("NEI"), NewcoGen-Long Reign Holding LLC ("NGLRH") and ST NewcoGen LLC ("STN", and together with NGG, NEI and NGLRH, the "NewcoGen Funds"). NG is also the general partner of AGTC Partners, L.P., which is the general partner of AGTC Advisors Fund, L.P. ("AGTCA") and Applied Genomic Technology Capital Fund, L.P. ("AGTCF", and together with AGTCA, the "AGTC Funds"). NG is a wholly-owned subsidiary of Flagship Ventures Management, Inc. ("Flagship"). Noubar Afeyan and Edwin M. Kania, Jr. are directors of Flagship and may be deemed to beneficially own the securities held by the NewcoGen Funds and the AGTC Funds. Each of Messrs. Afeyan and Kania disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Noubar Afeyan and Edwin M. Kania, Jr. are managers of Flagship Ventures 2007 General Partner, LLC, which is the general partner of Flagship Ventures Fund 2007, L.P., and may be deemed to beneficially own the securities held by Flagship Ventures Fund 2007, L.P. Each of Messrs. Afeyan and Kania disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Noubar Afeyan and Edwin M. Kania, Jr. are managing members of OneLiberty Partners 2000, LLC, which is the general partner of OneLiberty Advisors Fund 2000 L.P. ("OLA") and OneLiberty Ventures 2000 L.P. ("OLV"), and may be deemed to beneficially own the securities held by OLA and OLV. Each of Messrs. Afeyan and Kania disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.